Results 11 to 20 of about 2,827,583 (304)

Pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized controlled trial

International Journal of Nephrology and Renovascular Disease, 2018
Osama Sawalmeh,1 Shaheed Moala,1 Zakaria Hamdan,2 Huda Masri,3 Khubaib Ayoub,4 Emad Khazneh,2 Mujahed Shraim5 1Medicine Department, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine; 2Nephrology Department ...
Sawalmeh O, Moala S, Hamdan Z, Masri H, Ayoub K, Khazneh E, Shraim M   +6 more
doaj   +1 more source

Home hemodialysis : is there still room for high dialysis solution flow rate ?

Bulletin de la Dialyse à Domicile, 2018
The availability in France, for the last decade, of low dialysate flow rate hemodialysis monitors, specifically adapted for daily hemodialysis (5 to 6 sessions per week), is contemporary with a real renewal of home hemodialysis.
Thierry Petitclerc
doaj   +1 more source

Regulation of plasma aldosterone during hemodialysis [PDF]

, 1990
In order to clarify the influence of serum potassium, serum sodium and plasma angiotensin II concentrations on aldosterone release during hemodialysis (HD), six chronic hemodialysis patients were studied during HD with varying dialysate sodium ...
B.K. Krämer, Ress, K. M., K.M. Ress, Müller, G. A., Krämer, Bernhard K., Ulshöfer, T. M., G.A. Müller, T.M. Ulshöfer, Risler, T., T. Risler   +9 more
core   +1 more source

Factors associated with cardiovascular events after simultaneous liver–kidney transplant from the US Multicenter Simultaneous Liver–Kidney Transplant Consortium

Hepatology Communications, EarlyView., 2022
Abstract Cardiovascular disease is a leading complication after both liver and kidney transplantation. Factors associated with and rates of cardiovascular events (CVEs) after simultaneous liver–kidney transplant (SLKT) are unknown. This was a retrospective cohort study of adult SLKT recipients between 2002 and 2017 at six centers in six United Network ...
Jennifer Jo, Gonzalo Crespo, Dyanna Gregory, Jasmine Sinha, Jiaheng Xie, Min Zhang, John Magee, Pranab Barman, Yuval A. Patel, Aaron Schluger, Kara Walters, Scott Biggins, Natalia Filipek, Giuseppe Cullaro, Randi Wong, Jennifer C. Lai, Gabriel J. Perreault, Elizabeth C. Verna, Pratima Sharma, Lisa B. VanWagner   +19 more
wiley   +1 more source

Effects of in-center daily hemodialysis upon mineral metabolism and bone disease in end-stage renal disease patients

São Paulo Medical Journal, 2001
CONTEXT: Alternative hemodialysis schedules have been proposed to improve the quality of the dialysis. Nonetheless, their influence upon mineral and bone disorders is unknown.
Jocemir Ronaldo Lugon, Mauro Barros André, Maria Eugênia Leite Duarte, Simone Martins Rembold, Elisa de Albuquerque Sampaio da Cruz   +4 more
doaj   +1 more source

Short daily versus conventional hemodialysis for hypertensive patients: a randomized cross-over study.

PLoS ONE, 2014
BackgroundTreatment of end stage renal disease patients with short daily hemodialysis has been associated with an improvement in blood pressure. It is unclear from these studies if anti-hypertensive management had been optimized prior to starting short ...
Deborah L Zimmerman, Marcel Ruzicka, Paul Hebert, Dean Fergusson, Rhian M Touyz, Kevin D Burns   +5 more
doaj   +1 more source

Ambrisentan use in a HIV-1 infected patient with end-stage renal disease and pulmonary hypertension: minimal removal by hemodialysis - a case report

BMC Nephrology, 2020
Background Ambrisentan is a selective endothelin receptor antagonist used for the treatment of pulmonary arterial hypertension (PAH). Little is known about ambrisentan removal by hemodialysis in patients with end-stage renal disease (ESRD).
José Ramón Santos, Ana Merino, Walter E. Haefeli, Cristina Miranda, Marisol Prats, Ioana Bancu, Lucía Bailón, José Moltó   +7 more
doaj   +1 more source

Disease severity adversely affects delivery of dialysis in acute renal failure [PDF]

, 2007
Background/Aims: Methods of intermittent hemodialysis (IHD) dose quantification in acute renal failure (ARF) are not well defined. This observational study was designed to evaluate the impact of disease activity on delivered single pool Kt/V-urea in ARF ...
Schiffl, Helmut
core   +1 more source

Impact of psychiatric comorbidity on quality of life and activities of daily living among patients suffering from chronic kidney disease undergoing hemodialysis

Industrial Psychiatry Journal, 2023
Introduction: Chronic Kidney Disease (CKD) is a debilitating illness that impairs an individual's physical and social functioning and ultimately affects the quality of life (QOL).
Ekram Goyal, Alka Puria, Suprakash Chaudhary, Ajay Kumar, Richa Raj, Sidhartha Kumar   +5 more
doaj   +1 more source

Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes [PDF]

, 1994
Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes. Anaphylactoid reactions (AR) are the most feared complications of hemodialysis.
Verresen, Luc, Lemke, Horst-Dieter, Vanrenterghem, Yves, Fink, Edwin, Yves Vanrenterghem, Edwin Fink, Horst-Dieter Lemke, Luc Verresen   +7 more
core   +1 more source